80_FR_14454 80 FR 14401 - Center for Scientific Review Notice of Closed Meetings

80 FR 14401 - Center for Scientific Review Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 53 (March 19, 2015)

Page Range14401-14402
FR Document2015-06268

Federal Register, Volume 80 Issue 53 (Thursday, March 19, 2015)
[Federal Register Volume 80, Number 53 (Thursday, March 19, 2015)]
[Notices]
[Pages 14401-14402]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-06268]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Eye Disease Mechanisms and Models.
    Date: April 14, 2015.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Alessandra C Rovescalli, Ph.D., Scientific 
Review Officer, National Institutes of Health, Center for Scientific 
Review, 6701 Rockledge Drive, Rm. 5205 MSC7846, Bethesda, MD 20892, 
(301) 435-1021, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Date: April 14, 2015.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Lynn E Luethke, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5166, MSC 7844, Bethesda, MD 
20892, (301) 806-3323, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; SEP: 4D Nucleome Network Organizational Hub.
    Date: April 15, 2015.
    Time: 1:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Allen Richon, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6184,

[[Page 14402]]

MSC 7892, Bethesda, MD 20892, 301-379-9351, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR14-247: Pharmacogenetics, Pharmacoepigenetics and 
Personalized Medicine in Children.
    Date: April 16, 2015.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD 
20892, 301-435-1779, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Ocular Diseases Pathophysiology and 
Therapeutic Approaches.
    Date: April 16, 2015.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Alessandra C Rovescalli, Ph.D., Scientific 
Review Officer, National Institutes of Health, Center for Scientific 
Review, 6701 Rockledge Drive, Rm. 5205 MSC7846, Bethesda, MD 20892, 
(301) 435-1021, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-13-190: Detection of Pathogen Induced Cancer.
    Date: April 17, 2015.
    Time: 12:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Gagan Pandya, Ph.D., Scientific Review Officer, 
National Institutes of Health, Center for Scientific Review, 6701 
Rockledge Drive, Rm. 3200, MSC 7808, Bethesda, MD 20892, 301-435-
1167, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: March 13, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-06268 Filed 3-18-15; 8:45 am]
 BILLING CODE 4140-01-P



                                                                            Federal Register / Vol. 80, No. 53 / Thursday, March 19, 2015 / Notices                                               14401

                                               A. Progress Reports                                     period will be required to address the                DEPARTMENT OF HEALTH AND
                                                  Program progress reports are required                FSRS reporting. For the full IHS award                HUMAN SERVICES
                                               semi-annually within 30 days after the                  term implementing this requirement
                                                                                                       and additional award applicability                    National Institutes of Health
                                               budget period ends. These reports must
                                               include a brief comparison of actual                    information, visit the DGM Grants
                                                                                                       Policy Web site at: https://www.ihs.gov/              Center for Scientific Review Notice of
                                               accomplishments to the goals                                                                                  Closed Meetings
                                               established for the period, or, if                      dgm/index.cfm?module=dsp_dgm_
                                               applicable, provide sound justification                 policy_topics.                                          Pursuant to section 10(d) of the
                                               for the lack of progress, and other                       Telecommunication for the hearing                   Federal Advisory Committee Act, as
                                               pertinent information as required. A                    impaired is available at: TTY (301) 443–              amended (5 U.S.C. App.), notice is
                                               final report must be submitted within 90                6394.                                                 hereby given of the following meetings.
                                               days of expiration of the budget/project                                                                        The meetings will be closed to the
                                               period.                                                 VII. Agency Contacts                                  public in accordance with the
                                                                                                                                                             provisions set forth in sections
                                               B. Financial Reports                                       1. Questions on the programmatic                   552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                       issues may be directed to: Ms. Patricia               as amended. The grant applications and
                                                 Federal Financial Report FFR (SF–
                                                                                                       Spotted Horse, Program Analyst, Office                the discussions could disclose
                                               425), Cash Transaction Reports are due
                                               30 days after the close of every calendar               of Direct Service and Contracting Tribes,             confidential trade secrets or commercial
                                               quarter to the Payment Management                       Indian Health Service, 801 Thompson                   property such as patentable material,
                                               Services, HHS at: http://                               Avenue, Suite 220, Rockville, MD                      and personal information concerning
                                               www.dpm.psc.gov. It is recommended                      20852–1609, Telephone: (301) 443–                     individuals associated with the grant
                                               that the applicant also send a copy of                  1104, Email: Patricia.SpottedHorse@                   applications, the disclosure of which
                                               the FFR (SF–425) report to the Grants                   ihs.gov.                                              would constitute a clearly unwarranted
                                               Management Specialist. Failure to                          2. Questions on grants management                  invasion of personal privacy.
                                               submit timely reports may cause a                       and fiscal matters may be directed to:                  Name of Committee: Center for Scientific
                                               disruption in timely payments to the                    Mr. Pallop Chareonvootitam, Grants                    Review Special Emphasis Panel; Member
                                               organization.                                           Management Specialist, Office of                      Conflict: Eye Disease Mechanisms and
                                                 Grantees are responsible and                          Management Services, Division of                      Models.
                                               accountable for accurate information                    Grants Management, 801 Thompson                         Date: April 14, 2015.
                                               being reported on all required reports:                 Avenue, TMP Suite 360, Rockville, MD                    Time: 8:00 a.m. to 2:00 p.m.
                                               The Progress Reports and Federal                        20852–1609, Telephone: (301) 443–                       Agenda: To review and evaluate grant
                                                                                                                                                             applications.
                                               Financial Report.                                       5204, Fax: (301) 443–9602, Email:                       Place: National Institutes of Health, 6701
                                                                                                       Pallop.Chareonvootitam@ihs.gov.                       Rockledge Drive, Bethesda, MD 20892,
                                               C. Federal Subaward Reporting System
                                               (FSRS)                                                     3. Questions on systems matters may                (Virtual Meeting).
                                                                                                       be directed to: Mr. Paul Gettys, Grant                  Contact Person: Alessandra C Rovescalli,
                                                  This award may be subject to the                                                                           Ph.D., Scientific Review Officer, National
                                                                                                       Systems Coordinator, Office of
                                               Transparency Act subaward and                                                                                 Institutes of Health, Center for Scientific
                                                                                                       Management Services, Division of                      Review, 6701 Rockledge Drive, Rm. 5205
                                               executive compensation reporting
                                                                                                       Grants Management, 801 Thompson                       MSC7846, Bethesda, MD 20892, (301) 435–
                                               requirements of 2 CFR part 170.
                                                                                                       Avenue, TMP Suite 360, Rockville, MD                  1021, rovescaa@mail.nih.gov.
                                                  The Transparency Act requires the
                                                                                                       20852, Phone: (301) 443–2114; or the                    Name of Committee: Center for Scientific
                                               OMB to establish a single searchable
                                                                                                       DGM main line (301) 443–5204, Fax:                    Review Special Emphasis Panel; Myalgic
                                               database, accessible to the public, with
                                                                                                       (301) 443–9602, Email: Paul.Gettys@                   Encephalomyelitis/Chronic Fatigue
                                               information on financial assistance
                                                                                                       ihs.gov.                                              Syndrome.
                                               awards made by Federal agencies. The                                                                            Date: April 14, 2015.
                                               Transparency Act also includes a                        VIII. Other Information                                 Time: 1:00 p.m. to 4:00 p.m.
                                               requirement for recipients of Federal                                                                           Agenda: To review and evaluate grant
                                               grants to report information about first-                  The PHS strongly encourages all                    applications.
                                               tier subawards and executive                            cooperative agreement and contract                      Place: National Institutes of Health, 6701
                                               compensation under Federal assistance                   recipients to provide a smoke-free                    Rockledge Drive, Bethesda, MD 20892,
                                               awards.                                                 workplace and promote the non-use of                  (Virtual Meeting).
                                                  IHS has implemented a Term of                        all tobacco products. In addition, Public               Contact Person: Lynn E Luethke, Ph.D.,
                                               Award into all IHS Standard Terms and                   Law 103–227, the Pro-Children Act of                  Scientific Review Officer, Center for
                                                                                                       1994, prohibits smoking in certain                    Scientific Review, National Institutes of
                                               Conditions, NoAs and funding                                                                                  Health, 6701 Rockledge Drive, Room 5166,
                                               announcements regarding the FSRS                        facilities (or in some cases, any portion             MSC 7844, Bethesda, MD 20892, (301) 806–
                                               reporting requirement. This IHS Term of                 of the facility) in which regular or                  3323, luethkel@csr.nih.gov.
                                               Award is applicable to all IHS grant and                routine education, library, day care,                   Name of Committee: Center for Scientific
                                               cooperative agreements issued on or                     health care, or early childhood                       Review Special Emphasis Panel; SEP: 4D
                                               after October 1, 2010, with a $25,000                   development services are provided to                  Nucleome Network Organizational Hub.
                                               subaward obligation dollar threshold                    children. This is consistent with the                   Date: April 15, 2015.
                                               met for any specific reporting period.                  HHS mission to protect and advance the                  Time: 1:00 p.m. to 6:00 p.m.
                                               Additionally, all new (discretionary)                   physical and mental health of the                       Agenda: To review and evaluate grant
Rmajette on DSK2VPTVN1PROD with NOTICES




                                               IHS awards (where the project period is                 American people.                                      applications.
                                               made up of more than one budget                                                                                 Place: National Institutes of Health, 6701
                                                                                                         Dated: March 12, 2015.                              Rockledge Drive, Bethesda, MD 20892,
                                               period) and where: 1) the project period                                                                      (Virtual Meeting).
                                                                                                       Robert G. McSwain,
                                               start date was October 1, 2010 or after                                                                         Contact Person: Allen Richon, Ph.D.,
                                               and 2) the primary awardee will have a                  Acting Director, Indian Health Service.
                                                                                                                                                             Scientific Review Officer, Center for
                                               $25,000 subaward obligation dollar                      [FR Doc. 2015–06353 Filed 3–18–15; 8:45 am]           Scientific Review, National Institutes of
                                               threshold during any specific reporting                 BILLING CODE 4165–16–P                                Health, 6701 Rockledge Drive, Room 6184,



                                          VerDate Sep<11>2014   15:18 Mar 18, 2015   Jkt 235001   PO 00000   Frm 00045   Fmt 4703   Sfmt 4703   E:\FR\FM\19MRN1.SGM   19MRN1


                                               14402                        Federal Register / Vol. 80, No. 53 / Thursday, March 19, 2015 / Notices

                                               MSC 7892, Bethesda, MD 20892, 301–379–                  DEPARTMENT OF HEALTH AND                              DEPARTMENT OF HEALTH AND
                                               9351, allen.richon@nih.hhs.gov.                         HUMAN SERVICES                                        HUMAN SERVICES
                                                 Name of Committee: Center for Scientific
                                               Review Special Emphasis Panel; PAR14–247:               National Institutes of Health                         Food and Drug Administration
                                               Pharmacogenetics, Pharmacoepigenetics and                                                                     [Docket No. FDA–2015–N–0620]
                                               Personalized Medicine in Children.                      National Heart, Lung, and Blood
                                                 Date: April 16, 2015.                                 Institute; Notice of Closed Meetings
                                                                                                                                                             An Interactive Discussion on the
                                                 Time: 10:00 a.m. to 12:00 p.m.                          Pursuant to section 10(d) of the                    Clinical Considerations of Risk in the
                                                 Agenda: To review and evaluate grant                  Federal Advisory Committee Act, as                    Postmarket Environment; Public
                                               applications.                                           amended (5 U.S.C. App.), notice is                    Workshop; Request for Comments
                                                 Place: National Institutes of Health, 6701            hereby given of the following meetings.
                                               Rockledge Drive, Bethesda, MD 20892,                      The meetings will be closed to the                  AGENCY:   Food and Drug Administration,
                                               (Telephone Conference Call).                            public in accordance with the                         HHS.
                                                 Contact Person: Elaine Sierra-Rivera, Ph.D.,          provisions set forth in sections                      ACTION: Notice of public workshop;
                                               Scientific Review Officer, Center for                   552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,            request for comments.
                                               Scientific Review, National Institutes of               as amended. The grant applications,
                                               Health, 6701 Rockledge Drive, Room 6184,                                                                         The Food and Drug Administration
                                                                                                       contract proposal, and the discussions                (FDA) is announcing a public workshop
                                               MSC 7804, Bethesda, MD 20892, 301–435–                  could disclose confidential trade secrets
                                               1779, riverase@csr.nih.gov.                                                                                   entitled ‘‘Clinical Considerations of Risk
                                                                                                       or commercial property such as                        in the Postmarket Environment.’’ The
                                                 Name of Committee: Center for Scientific              patentable material, and personal
                                               Review Special Emphasis Panel; Member
                                                                                                                                                             purpose of this workshop is to provide
                                                                                                       information concerning individuals                    a forum for an interactive discussion on
                                               Conflict: Ocular Diseases Pathophysiology               associated with the grant applications or
                                               and Therapeutic Approaches.
                                                                                                                                                             assessing changes in medical device risk
                                                                                                       contract proposal, the disclosure of                  as quality and safety situations arise in
                                                 Date: April 16, 2015.                                 which would constitute a clearly
                                                 Time: 10:00 a.m. to 3:00 p.m.                                                                               the postmarket setting when a patient,
                                                                                                       unwarranted invasion of personal                      operator, or member of the public uses
                                                 Agenda: To review and evaluate grant                  privacy.
                                               applications.                                                                                                 the device. FDA is interested in
                                                 Place: National Institutes of Health, 6701              Name of Committee: National Heart, Lung,            obtaining input from stakeholders about
                                                                                                       and Blood Institute Special Emphasis Panel;           assessing risk postmarket when new
                                               Rockledge Drive, Bethesda, MD 20892,
                                                                                                       Clinical Research in HIV/HLB Diseases.                hazards develop in the postmarket
                                               (Virtual Meeting).                                        Date: April 13, 2015.
                                                 Contact Person: Alessandra C Rovescalli,                                                                    setting that were not present or not
                                                                                                         Time: 8:00 a.m. to 5:00 p.m.
                                               Ph.D., Scientific Review Officer, National                Agenda: To review and evaluate grant                known at the time of clearance or
                                               Institutes of Health, Center for Scientific             applications.                                         approval or hazards were anticipated,
                                               Review, 6701 Rockledge Drive, Rm. 5205                    Place: The Dupont Circle Hotel, 1500 New            but harm occurs at an unexpected rate
                                               MSC7846, Bethesda, MD 20892, (301) 435–                 Hampshire Avenue NW., Washington, DC                  or in unexpected populations or use
                                               1021, rovescaa@mail.nih.gov.                            20036.                                                environments. Comments and
                                                                                                         Contact Person: Stephanie L Constant,               suggestions generated through this
                                                 Name of Committee: Center for Scientific
                                                                                                       Ph.D. Scientific Review Officer, Office of            workshop will facilitate the assessment
                                               Review Special Emphasis Panel; PAR–13–                  Scientific Review/DERA, National Heart,
                                               190: Detection of Pathogen Induced Cancer.                                                                    of risk in postmarket quality and safety
                                                                                                       Lung, and Blood Institute, 6701 Rockledge
                                                 Date: April 17, 2015.                                 Drive, Room 7189, Bethesda, MD 20892, 301–
                                                                                                                                                             situations.
                                                 Time: 12:00 p.m. to 6:00 p.m.                         443–8784 constantsl@nhlbi.nih.gov.                       Date and Time: The public workshop
                                                 Agenda: To review and evaluate grant                                                                        will be held on April 21, 2015, from
                                                                                                         Name of Committee: National Heart, Lung,
                                               applications.                                           and Blood Institute Special Emphasis Panel;           8:30 a.m. to 5 p.m.
                                                 Place: National Institutes of Health, 6701            Improving Red Blood Cells for Transfusion.               Location: The public workshop will
                                               Rockledge Drive, Bethesda, MD 20892.                      Date: April 13, 2015.                               be held at FDA’s White Oak Campus,
                                                 Contact Person: Gagan Pandya, Ph.D.,                    Time: 12:00 p.m. to 2:00 p.m.                       10903 New Hampshire Ave., Building
                                               Scientific Review Officer, National Institutes            Agenda: To review and evaluate contract             31 Conference Center, the Great Room
                                               of Health, Center for Scientific Review, 6701           proposals.                                            (Rm. 1503), Silver Spring, MD 20993–
                                                                                                         Place: National Institutes of Health, 6701          0002. Entrance for the public meeting
                                               Rockledge Drive, Rm. 3200, MSC 7808,
                                                                                                       Rockledge Drive, Room 7198, Bethesda, MD              participants (non-FDA employees) is
                                               Bethesda, MD 20892, 301–435–1167,                       20892 (Telephone Conference Call).
                                               pandyaga@mai.nih.gov.                                     Contact Person: Kristin Goltry, Ph.D.
                                                                                                                                                             through Building 1 where routine
                                               (Catalogue of Federal Domestic Assistance               Scientific Review Officer, Office of Scientific       security check procedures will be
                                               Program Nos. 93.306, Comparative Medicine;              Review/DERA, National Heart, Lung, and                performed. For parking and security
                                               93.333, Clinical Research, 93.306, 93.333,              Blood Institute, 6701 Rockledge Drive, Room           information, please refer to: http://
                                               93.337, 93.393–93.396, 93.837–93.844,                   7198, Bethesda, MD 20892, 301–435–0297,               www.fda.gov/AboutFDA/
                                                                                                       goltrykl@mail.nih.gov.                                WorkingatFDA/BuildingsandFacilities/
                                               93.846–93.878, 93.892, 93.893, National
                                               Institutes of Health, HHS)                              (Catalogue of Federal Domestic Assistance             WhiteOakCampusInformation/
                                                                                                       Program Nos. 93.233, National Center for              ucm241740.htm.
                                                 Dated: March 13, 2015.                                Sleep Disorders Research; 93.837, Heart and              Contact Person: Jean M. Cooper,
                                               Anna Snouffer,                                          Vascular Diseases Research; 93.838, Lung              Center for Devices and Radiological
                                                                                                       Diseases Research; 93.839, Blood Diseases
                                               Deputy Director, Office of Federal Advisory                                                                   Health, Food and Drug Administration,
                                                                                                       and Resources Research, National Institutes
                                               Committee Policy.                                                                                             10903 New Hampshire Ave., Bldg. 66,
Rmajette on DSK2VPTVN1PROD with NOTICES




                                                                                                       of Health, HHS)
                                               [FR Doc. 2015–06268 Filed 3–18–15; 8:45 am]                                                                   Rm. 5540, Silver Spring, MD 20993,
                                                                                                         Dated: March 13, 2015.                              301–796–6141, email: Jean.Cooper@
                                               BILLING CODE 4140–01–P
                                                                                                       Michelle Trout,                                       fda.hhs.gov.
                                                                                                       Program Analyst, Office of Federal Advisory              Registration: Registration is free and
                                                                                                       Committee Policy.                                     available on a first-come, first-served
                                                                                                       [FR Doc. 2015–06269 Filed 3–18–15; 8:45 am]           basis. Persons interested in attending
                                                                                                       BILLING CODE 4140–01–P                                this public workshop must register


                                          VerDate Sep<11>2014   15:18 Mar 18, 2015   Jkt 235001   PO 00000   Frm 00046   Fmt 4703   Sfmt 4703   E:\FR\FM\19MRN1.SGM   19MRN1



Document Created: 2018-02-21 09:42:12
Document Modified: 2018-02-21 09:42:12
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesApril 14, 2015.
FR Citation80 FR 14401 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR